Capital Stock	12 Months Ended
Dec. 31, 2017
Equity [Abstract]
Capital Stock	12. CAPITAL STOCK: Common and Preferred Stock- The Company’s stockholders had authorized 48.0 million shares of common stock available for issuance as of December 31, 2017 and 2016, and had 2.0 million shares of preferred stock available for issuance as of December 31, 2017 and 2016. Stock Repurchase Program- In December 2007, our Board of Directors (the “Board”) authorized a stock repurchase program for up to $5.0 million of common stock on the open market or through privately negotiated transactions from time-to-time through December 31, 2008 (the “Stock Repurchase Program”). The Board subsequently amended the Stock Repurchase Program, authorizing both an increase to and an extension of the Stock Repurchase Program. The Stock Repurchase Program, as amended, had a maximum purchase value of shares of $23.1 million (the “Purchase Authorization”) and was set to expire on September 22, 2017 (the “Repurchase Period”). On September 20, 2017, we announced that the Board had approved an extension of the Repurchase Period to September 21, 2018. The timing and amount of the purchases will be based upon market conditions, securities law considerations and other factors. The Stock Repurchase Program does not obligate the Company to acquire a specific number of shares in any period and may be modified, suspended, extended or discontinued at any time, without prior notice. The Company repurchased 199,053 shares of common stock at an aggregate price of $1.3 million during the year ended December 31, 2017. The Company did not repurchase any shares of common stock during the year ended December 31, 2016. As of December 31, 2017, the Company had $7.4 million of purchase authorization remaining under the plan.

12. CAPITAL STOCK:

Common and Preferred Stock-

The Company’s stockholders had authorized 48.0 million shares of common stock available for issuance as of December 31, 2017 and 2016, and had 2.0 million shares of preferred stock available for issuance as of December 31, 2017 and 2016.

Stock Repurchase Program-

In December 2007, our Board of Directors (the “Board”) authorized a stock repurchase program for up to $5.0 million of common stock on the open market or through privately negotiated transactions from time-to-time through December 31, 2008 (the “Stock Repurchase Program”). The Board subsequently amended the Stock Repurchase Program, authorizing both an increase to and an extension of the Stock Repurchase Program. The Stock Repurchase Program, as amended, had a maximum purchase value of shares of $23.1 million (the “Purchase Authorization”) and was set to expire on September 22, 2017 (the “Repurchase Period”). On September 20, 2017, we announced that the Board had approved an extension of the Repurchase Period to September 21, 2018.

The timing and amount of the purchases will be based upon market conditions, securities law considerations and other factors. The Stock Repurchase Program does not obligate the Company to acquire a specific number of shares in any period and may be modified, suspended, extended or discontinued at any time, without prior notice.

The Company repurchased 199,053 shares of common stock at an aggregate price of $1.3 million during the year ended December 31, 2017. The Company did not repurchase any shares of common stock during the year ended December 31, 2016. As of December 31, 2017, the Company had $7.4 million of purchase authorization remaining under the plan.